Watch AVBP. Know when insiders buy.
One email the day a filing lands. Free.
AVBP
ArriVent BioPharma, Inc.
19.20
+0.08 +0.42%
USD · close Oct 22
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · shorts 37
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $946.7MP/E —DIV YIELD —FCF YIELD —REV TTM —NET INCOME −$163.7MNET CASH —52W 15.09 – 34.74SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose AVBP in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
Vivo Opportunity, LLC and 5 related5.0%
ORBIMED ADVISORS LLC and 3 related5.8%
“The Shares acquired by the Reporting Persons were acquired for the purpose of making an investment in the Issuer and not with the intention of acquiring control of the Issuer's business on behalf of the Reporting Persons' respective advisory clients. The Reporting Persons from time to time intend to…”
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.